Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
22.16
+0.36 (+1.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Guardant Health Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Analyst Expectations for Guardant Health's Future
September 27, 2023
Via
Benzinga
Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases
September 26, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 26, 2023 – USA News Group – The seriousness of pancreatic cancer continues to grow, with increasing alarm since The...
Via
FinancialNewsMedia
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.
Via
Benzinga
Exposures
COVID-19
The Latest Analyst Ratings for Guardant Health
August 04, 2023
Via
Benzinga
Preview: Guardant Health's Earnings
August 02, 2023
Via
Benzinga
Analyst Ratings for Guardant Health
May 26, 2023
Via
Benzinga
Guardant Health Receives Coverage for Guardant Reveal™ from Geisinger Health Plan
September 06, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Receives Regulatory Approval in Japan for Guardant360® CDx as Companion Diagnostic to ENHERTU® for Treatment of Non-Small Cell Lung Cancer Patients with HER2 Mutations
September 05, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Provides Update on COBRA Study, Restates Confidence in MRD Test
September 01, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 31, 2023
From
Guardant Health, Inc.
Via
Business Wire
Why Shares of Guardant Health Jumped This Week
May 19, 2023
The cancer diagnostic company saw its shares take a big jump for the second straight week.
Via
The Motley Fool
Guardant Health to Host Investor Day on September 7, 2023
August 17, 2023
From
Guardant Health, Inc.
Via
Business Wire
2 Cathie Wood Stocks to Buy and Hold for 10 Years
August 10, 2023
These companies' growth stories still have plenty of exciting chapters ahead.
Via
The Motley Fool
Guardant Health Stock Sees Renewed Technical Strength
August 07, 2023
Guardant Health stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 79 to 85.
Via
Investor's Business Daily
Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance
August 03, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research
August 01, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health receives first commercial payor coverage for Guardant Reveal™ test from Blue Cross and Blue Shield of Louisiana
July 20, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Report Second Quarter 2023 Financial Results on August 3, 2023
July 12, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health announces reimbursement approval of Guardant360® CDx liquid biopsy test in Japan
July 05, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Stock Reaches 80-Plus Relative Strength Rating Benchmark
June 23, 2023
On Friday, Guardant Health stock hit a key performance benchmark, with its Relative Strength Rating rising to 82, up from 78 the day before.
Via
Investor's Business Daily
Guardant Health to present 17 scientific abstracts highlighting contribution of its blood tests and real-world data to advances in precision oncology and cancer screening at 2023 ASCO annual meeting
May 31, 2023
From
Guardant Health, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2023
May 26, 2023
Via
Benzinga
Guardant Health to Participate in Upcoming June Investor Conferences
May 26, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Shares Move Lower On $350M Public Offering: The Details
May 23, 2023
Guardant Health Inc (NASDAQ: GH) shares are trading lower Tuesday after the company announced an offering.
Via
Benzinga
Guardant Health Announces Pricing of Upsized Public Offering of Common Stock
May 22, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces Proposed Public Offering of Common Stock
May 22, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Secures Coverage From Major US Commercial Health Insurers for Guardant360® Blood Test for Comprehensive Genomic Profiling
May 17, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Releases Inaugural ESG Report
May 16, 2023
From
Guardant Health, Inc.
Via
Business Wire
Why Guardant Health's Shares Climbed This Week
May 11, 2023
The company, which focuses on oncology screenings, saw a big gain in revenue in the first quarter.
Via
The Motley Fool
A New Groundbreaking Tool to Detect Colon Cancer Earlier
May 10, 2023
A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This...
Via
PressReach
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.